Since the use of animal insulin for the treatment of diabetes in 1922, about nine major classes of drugs for the treatment of diabetes have been discovered and developed worldwide, including sulfonylureas, biguanides, -glucosidase inhibitors, insulins, thiazolidinediones (TZDs), meglitinides, GLP-1RAs, DPP-4 inhibitors, and SGLT-2 inhibitors
Like most medications, GLP-1s have potential side effects
Savings limits apply, and the costs of medication purchased through NovoCare do not apply to out-of-pocket limits and deductibles
Do the math on 20 new weight-loss patients per month through a platform model: Compare that to spending $80,000/year on marketing ($4k/month optimistic budget) hoping to generate the same patient volume
High stress levels can also influence the gut microbiome and insulin sensitivity, creating the kind of metabolic environment where energy dips, cravings and late-afternoon slumps become more common